China Resources Double-Crane Pharmaceutical Co Ltd

China Resources Double-Crane Pharmaceutical Co Ltd

600062 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

15.22CNY-0.12 (-0.78%)

Price History

Full chart

Market Stats

Previous Close15.34
Open15.30
Day Range15.21 – 15.35
52-Week Range15.29 – 19.77
Volume6.07M
Market Cap16.87B
P/E (TTM)10.41
Forward P/E12.35
EPS1.56
Dividend Yield2.95%
Beta-0.08
50-Day Avg16.18
200-Day Avg17.45

About

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People's Republic of China. The company offers pharmaceutical products for blood pressure and sugar, injections, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, inflammation, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People's Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing Pharmaceutical Group Co., Ltd.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Qian Zhao
  • Employees13.18K
  • HeadquartersNo. 1, Lize East 2nd Road, Beijing, China, 100102, China
  • Websitehttps://www.dcpc.com

Leadership

  • Mr. Qian ZhaoPresident & Director · b. 1982
  • Mr. Wen Hao HuangChief Financial Officer · b. 1984
  • Mr. Ju LiuBoard Secretary & VP · b. 1973
  • Mr. Chao ManVice President · b. 1971
  • Mr. Hekai TanVice President · b. 1973
  • Chang Jiu YuAccounting Supervisor

Financials

Income Statement

Currency: CNY1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue156.72M168.11M208.44M236.31M350.67M723.17M1.17B2.38B3.69B4.25B4.20B4.60B4.05B4.56B4.95B5.04B5.37B6.34B6.99B6.83B5.15B5.14B5.49B6.42B8.23B9.38B8.50B9.11B9.63B11.31B11.21B11.00B
Growth (%)-+7.27%+23.99%+13.37%+48.39%+106.23%+61.56%+103.94%+54.71%+15.27%-1.26%+9.57%-11.93%+12.53%+8.67%+1.75%+6.53%+18.08%+10.29%-2.21%-24.60%-0.29%+6.94%+16.87%+28.08%+14.05%-9.35%+7.14%+5.64%+17.50%-0.87%-1.88%
Cost of Revenue107.00M103.37M131.11M160.91M227.24M447.54M633.99M1.50B2.54B3.10B3.09B3.37B2.90B3.19B3.42B3.33B3.42B4.32B4.67B4.48B2.53B2.50B2.60B2.75B3.03B3.45B3.16B4.05B4.31B4.90B4.83B4.62B
Gross Profit49.72M64.74M77.34M75.40M123.43M275.63M534.35M882.23M1.14B1.15B1.11B1.23B1.15B1.37B1.53B1.71B1.94B2.06B2.32B2.35B2.63B2.64B2.90B3.67B5.20B5.93B5.35B5.06B5.32B6.41B6.38B6.38B
Gross Margin31.73%38.51%37.10%31.91%35.20%38.11%45.74%37.03%30.97%27.12%26.45%26.80%28.31%30.07%30.98%33.95%36.18%32.54%33.13%34.44%51.00%51.38%52.76%57.20%63.20%63.22%62.87%55.57%55.25%56.64%56.91%58.01%
Operating Expense18.05M20.59M26.67M26.55M49.91M182.41M360.77M701.93M933.25M1.04B996.78M962.24M920.88M976.60M1.08B1.18B1.36B1.42B1.63B1.32B1.79B1.88B2.05B2.61B4.01B4.67B4.12B3.93B3.89B4.53B4.55B4.53B
Operating Income31.68M44.15M50.66M48.86M73.51M93.22M173.58M180.30M208.25M116.71M113.02M270.03M225.44M393.76M452.03M534.52M584.62M644.35M680.89M1.03B839.14M764.33M847.32M1.06B1.19B1.26B1.23B1.14B1.43B1.88B1.83B1.86B
Operating Margin20.21%26.27%24.31%20.67%20.96%12.89%14.86%7.57%5.65%2.75%2.69%5.87%5.57%8.64%9.13%10.61%10.89%10.17%9.74%15.13%16.28%14.87%15.42%16.51%14.46%13.46%14.46%12.48%14.83%16.63%16.36%16.86%
EBITDA-14.10M48.00M53.62M47.83M81.48M164.37M213.35M292.08M332.48M255.28M198.39M408.31M384.66M562.61M588.28M711.41M787.33M902.96M981.84M1.36B1.16B1.08B1.23B1.39B1.54B1.63B1.59B1.58B1.99B2.62B2.60B2.73B
EBITDA Margin-9.00%28.55%25.73%20.24%23.24%22.73%18.26%12.26%9.02%6.01%4.73%8.88%9.50%12.35%11.88%14.12%14.67%14.25%14.05%19.95%22.53%21.09%22.30%21.67%18.70%17.40%18.74%17.35%20.65%23.15%23.19%24.84%
Net Income31.46M43.99M50.66M47.55M60.88M75.89M108.44M152.02M168.44M63.36M4.71M185.49M164.89M437.58M380.57M454.02M520.09M529.00M614.41M870.69M736.62M661.06M714.21M842.61M968.59M1.06B1.01B935.69M1.18B1.67B1.63B1.65B
Net Income Margin20.07%26.17%24.31%20.12%17.36%10.49%9.28%6.38%4.57%1.49%0.11%4.03%4.07%9.60%7.69%9.01%9.69%8.35%8.79%12.74%14.29%12.87%13.00%13.12%11.78%11.25%11.82%10.27%12.26%14.77%14.52%14.97%
R&D----------------100.77M109.70M82.00M93.46M169.01M188.55M120.55M152.20M144.74M202.01M291.02M409.59M482.48M627.85M725.55M531.60M
R&D as % of Total Revenue----------------1.88%1.73%1.17%1.37%3.28%3.67%2.19%2.37%1.76%2.15%3.42%4.50%5.01%5.55%6.47%4.83%
Interest Expense3.94M3.84M2.96M--12.00M18.07M28.20M37.28M48.38M46.81M49.37M26.99M11.43M12.80M15.56M1.25M9.68M4.25M28.81M12.55M7.14M2.95M703.63K9.32M10.55M4.21M12.55M11.95M16.97M16.77M33.58M
Interest Expense % of Total Revenue2.51%2.29%1.42%--1.66%1.55%1.18%1.01%1.14%1.12%1.07%0.67%0.25%0.26%0.31%0.02%0.15%0.06%0.42%0.24%0.14%0.05%0.01%0.11%0.11%0.05%0.14%0.12%0.15%0.15%0.31%

Balance Sheet

Currency: CNY1994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets131.33M132.29M154.30M574.69M741.02M1.18B1.48B2.75B3.62B4.26B4.03B3.81B3.26B3.67B4.27B4.72B5.21B6.08B6.51B6.48B6.62B7.76B8.24B9.44B10.31B11.28B12.42B13.68B14.48B15.43B16.69B17.01B
Total Liabilities36.42M29.17M48.49M101.78M199.57M473.60M628.89M1.26B2.01B2.54B2.30B1.87B1.26B1.31B1.12B1.18B1.28B1.73B1.80B1.14B934.93M1.33B1.20B1.59B2.40B2.60B3.04B3.20B3.75B3.64B5.57B4.51B
Total Equity94.91M103.12M105.81M472.91M534.00M692.21M790.56M1.28B1.40B1.49B1.54B1.73B1.82B2.20B3.08B3.47B3.86B4.26B4.65B5.33B5.68B6.11B6.69B7.46B7.84B8.60B9.29B9.91B10.02B11.09B10.41B11.63B
Cash1.08M14.28M9.17M337.90M140.66M318.75M204.46M555.30M513.67M444.69M573.68M668.57M451.96M654.29M1.03B1.02B1.06B1.10B1.00B1.41B1.37B778.24M1.49B1.25B1.10B1.84B2.41B2.83B2.63B3.46B2.85B1.91B
Total Debt-400.00K35.50M75.00M115.99M188.88M250.32M426.51M706.41M1.08B889.53M721.89M318.50M311.00M341.50M278.00M292.80M400.75M295.00M210.00M1.22M41.22M-322.12K81.96M64.86M6.63M64.90M264.99M59.92M1.18B1.16B
Net Debt-1.08M-13.88M26.33M-262.90M-24.67M-129.87M45.86M-128.79M192.74M635.04M315.85M53.32M-133.46M-343.29M-686.93M-745.52M-763.82M-703.76M-709.71M-1.20B-1.37B-737.02M-1.49B-1.25B-1.02B-1.78B-2.40B-2.77B-2.37B-3.40B-1.68B-758.00M

Cash Flow

Currency: CNY1998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-13.78M131.54M172.81M141.01M140.63M148.94M453.72M139.78M303.71M235.46M331.71M342.01M509.67M511.53M396.05M546.24M718.38M701.35M771.25M1.19B1.47B1.44B1.36B1.34B1.34B1.65B1.83B1.49B
Investing Cash Flow-144.17M-98.77M-252.21M-73.27M-304.66M-472.90M-152.36M109.66M-87.86M26.60M-169.95M-231.61M-307.75M-404.20M-208.27M98.87M-352.32M-710.13M163.30M-1.13B-823.49M-1.07B-417.98M-569.80M666.78M-707.76M982.46M-1.05B
Financing Cash Flow-39.29M145.32M-34.88M283.09M122.40M254.98M-172.37M-163.32M-403.36M-103.10M262.15M-164.29M-154.01M-55.81M-332.25M-110.70M-409.75M-583.89M-224.69M-293.45M-803.14M-524.86M-386.18M-378.62M-1.29B-358.32M-3.18B-1.37B
Capital Expenditure130.29M69.86M86.83M175.58M251.99M375.98M196.84M127.13M171.66M136.17M309.20M285.16M370.18M338.78M221.89M217.68M142.38M168.49M110.04M154.82M228.69M241.65M348.09M491.67M525.53M614.31M637.50M619.63M
Free Cash Flow-144.07M61.67M85.98M-34.57M-111.35M-227.05M256.88M12.64M132.05M99.29M22.51M56.85M139.50M172.74M174.16M328.56M576.00M532.86M661.20M1.03B1.24B1.20B1.01B849.25M816.14M1.03B1.19B869.88M
Dividends Paid8.92M-41.58M56.21M67.98M89.14M48.10M43.88M106.38M93.17M111.28M79.88M145.73M155.00M250.84M217.22M199.75M3.36M184.69M193.72M91.11M291.06M317.14M302.54M799.19M300.48M1.48B716.05M
FCF to OCF1045.32%46.89%49.75%-24.52%-79.18%-152.44%56.62%9.04%43.48%42.17%6.79%16.62%27.37%33.77%43.97%60.15%80.18%75.98%85.73%86.96%84.43%83.22%74.41%63.33%60.83%62.17%65.07%58.40%
Dividend Paid to FCF-6.19%-48.36%-162.58%-61.04%-39.26%18.72%347.16%80.56%93.84%494.39%140.50%104.47%89.73%144.03%66.11%34.68%0.63%27.93%18.77%7.35%24.29%31.34%35.62%97.92%29.28%124.56%82.32%

Earnings

Report DateOct 22, 2009Oct 25, 2013Mar 11, 2014Aug 25, 2014Oct 27, 2014Mar 12, 2015Apr 27, 2015Aug 26, 2015Oct 29, 2015Mar 10, 2016Apr 27, 2016Aug 15, 2016Oct 31, 2016Mar 9, 2017Apr 26, 2017Aug 17, 2017Oct 24, 2017Mar 14, 2018Apr 23, 2018Aug 22, 2018Oct 28, 2018Mar 14, 2019Apr 26, 2019Aug 21, 2019Oct 29, 2019Mar 20, 2020Apr 24, 2020Aug 24, 2020Oct 29, 2020Mar 18, 2021Apr 28, 2021Aug 23, 2021Oct 29, 2021Mar 24, 2022Apr 28, 2022Aug 23, 2022Oct 25, 2022Mar 27, 2023Apr 27, 2023
EPS Estimate0.130.200.200.240.280.130.260.220.250.470.200.270.280.320.220.320.240.310.200.270.160.100.210.240.20--------------
EPS Actual0.150.220.140.200.140.130.190.200.120.160.150.240.150.110.230.220.190.110.290.270.250.120.320.270.270.130.260.270.310.130.270.300.280.050.320.400.230.170.36
Surprise15.38%10.00%-30.00%-16.67%-50.00%0.00%-26.92%-9.09%-52.00%-65.96%-25.00%-11.11%-46.43%-65.63%4.55%-31.25%-20.83%-64.52%45.00%0.00%56.25%20.00%52.38%12.50%35.00%--------------
TimingPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursPre-market

Key Statistics & Ratios

Market Cap16.87B
Enterprise Value15.07B
Trailing P/E10.41
Forward P/E12.35
Price / Sales1.56
Price / Book1.36
EPS1.56
Book Value11.86
Revenue (TTM)10.80B
Gross Profit (TTM)6.11B
EBITDA2.33B
Profit Margin14.94%
Operating Margin16.13%
Return on Equity13.16%
Return on Assets5.56%
Shares Outstanding1.04B
Shares Float399.90M
Beta-0.08
Dividend Yield2.95%
Dividend Rate0.48
Payout Ratio30.21%

Dividends

20231×
0.29Jul 13, 2023
20222×
0.29Sep 28, 20220.48Jun 16, 2022
20211×
0.29Jul 13, 2021
20201×
0.30Jul 17, 2020
20191×
0.28Jul 19, 2019
20181×
0.10Aug 16, 2018
20171×
0.08Jul 17, 2017
20161×
0.13Jul 20, 2016
20141×
0.24Jul 10, 2014
20131×
0.22Jun 28, 2013
20121×
0.27Jul 20, 2012
20111×
0.16Jul 4, 2011
20101×
0.16Jul 2, 2010
20091×
0.08Jul 16, 2009
20081×
0.11Jun 17, 2008
20071×
0.09Jun 11, 2007
20061×
0.10Jul 3, 2006
20031×
0.06May 22, 2003
20021×
0.04May 13, 2002
20011×
0.04Apr 24, 2001
20001×
0.03Apr 27, 2000

Stock Splits

  • Aug 16, 20186:5
  • Jul 17, 20176:5